Frencken - RHB Invest 2024-08-23: Recovery At Play; Maintain BUY

Frencken - Recovery At Play; Maintain BUY

Published:
Frencken (SGX:E28) | SGinvestors.ioFrencken (SGX:E28)
  • We maintain our positive stance on Frencken (SGX:E28) even though 1H24’s results were slower than expected. Nonetheless, we see Frencken as a beneficiary of the anticipated semiconductor recovery going forward.
  • - Read this at SGinvestors.io -
  • Frencken's share price trades at ~12x FY25F earnings P/E, i.e. near its historical mean average.

1H24 slower than expected.

  • Frencken's 1H24 revenue grew 6.2% y-o-y to S$373m while earnings surged 50% y-o-y to S$18m on the back of recovering topline and better gross margins. Revenue growth was mainly driven by the mechatronics division, which grew by 8% y-o-y to S$327m, offset by the integrated manufacturing services (IMS) division’s 4% y-o-y revenue decline to S$44m.
  • - Read this at SGinvestors.io -
  • Gross margin rose by 2.5ppts to 14.8% from better operating leverage. EBIT grew 42% y-o-y to S$26m on better gross margins and opex.

FY24F earnings change (-11.6%). with FY25 and FY26F earnings cut by 7.6% each.

  • Read more at SGinvestors.io.





Alfie Yeo RHB Securities Research | https://www.rhbgroup.com/ 2024-08-23



Read also RHB's most recent report:
2024-11-21 Frencken - Semiconductor Sector Recovery Still In Play; BUY.

Price targets by 4 other brokers at Frencken Target Prices.

Listing of research reports at Frencken Analyst Reports.

Relevant links:
Frencken Share Price History,
Frencken Announcements,
Frencken Dividends & Corporate Actions,
Frencken News Articles





Advertisement

You May Also Like




SGX Stock / REIT Search

Advertisement

Most Read

Trust Bank Referral Code

Advertisement